Assessing renal function in cirrhotic patients: Problems and pitfalls

被引:238
作者
Sherman, DS
Fish, DN
Teitelbaum, I
机构
[1] Univ Colorado, Hlth Sci Ctr, Sch Pharm, Dept Pharm Practice, Denver, CO 80262 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Med, Div Renal Dis & Hypertens, Denver, CO 80262 USA
[3] Univ Colorado, Hlth Sci Ctr, Dept Pharm, Univ Colorado Hosp, Denver, CO 80262 USA
关键词
creatine; creatinine; glomerular filtration rate (GFR); kidney function tests; inulin; liver diseases; liver function tests;
D O I
10.1053/ajkd.2003.50035
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Assessment of glomerular filtration rate (GFR) by common creatinine-based methods potentially is very inaccurate in patients with cirrhosis. Cirrhotic patients have several underlying conditions that contribute to falsely low serum creatinine concentrations, even in the presence of moderate to severe renal impairment, and often cause creatinine-based methods to overestimate true GFR. Such underlying conditions include decreased creatinine production secondary to decreased hepatic creatine synthesis, increased tubular creatinine secretion, and decreased skeletal muscle mass. These factors all contribute to serum creatinine concentrations that often do not accurately reflect renal function. Serum creatinine level, measured creatinine clearance, and calculated creatinine clearance may all significantly overestimate GFR; the degree of GFR overestimation was a median of 95% in published studies. Until more accurate methods of estimating GFR in cirrhotic patients are adequately validated, care should be exercised in the management of these patients because of the potential for severely impaired renal function, even in the face of normal serum creatinine concentrations. Am J Kidney Dis 41:269-276. (C) 2003 by the National Kidney Foundation, Inc.
引用
收藏
页码:269 / 278
页数:10
相关论文
共 37 条
  • [1] ADITHAN C, 1981, Indian Journal of Medical Sciences, V35, P233
  • [2] Amarapurkar D N, 1994, Indian J Gastroenterol, V13, P79
  • [3] Bataller R, 1998, KIDNEY INT, V53, pS47
  • [4] BAUMANN TJ, 1987, CLIN PHARMACY, V6, P393
  • [5] Beyne P, 1996, CLIN CHEM, V42, P988
  • [6] LIMITATIONS OF SERUM CREATININE LEVEL AND CREATININE CLEARANCE AS FILTRATION MARKERS IN CIRRHOSIS
    CAREGARO, L
    MENON, F
    ANGELI, P
    AMODIO, P
    MERKEL, C
    BORTOLUZZI, A
    ALBERINO, F
    GATTA, A
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (02) : 201 - 205
  • [7] DECREASED RATE OF CREATININE PRODUCTION IN PATIENTS WITH HEPATIC-DISEASE - IMPLICATIONS FOR ESTIMATION OF CREATININE CLEARANCE
    COCCHETTO, DM
    TSCHANZ, C
    BJORNSSON, TD
    [J]. THERAPEUTIC DRUG MONITORING, 1983, 5 (02) : 161 - 168
  • [8] PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE
    COCKCROFT, DW
    GAULT, MH
    [J]. NEPHRON, 1976, 16 (01) : 31 - 41
  • [9] DAUGHERTY NA, 1978, CLIN CHEM, V24, P392
  • [10] Diagnostic value of serum cystatin C for evaluation of hepatorenal syndrome
    Demirtas, S
    Bozbas, A
    Akbay, A
    Yavuz, Y
    Karaca, L
    [J]. CLINICA CHIMICA ACTA, 2001, 311 (02) : 81 - 89